CT-100 (CisThera)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCT-100 (CisThera)
Drug Alias NamePAI-1 modulator (CisThera)Plasminogen Activator Inhibitor-1 Modulator (CisThera)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionPlasminogen activator inhibitor 1 modulators
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCisThera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCisThera Inc
Active IndicationsN/A
Inactive IndicationsKidney Diseases

Other Information

ATC CodeN/A
Related LinksN/A